NCT04572451
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma treatment 1 recruiting NCT02266745
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts treatment 2 active_not_recruiting NCT01918605
Protection of Rectum From High Radiation Doses Using a Spacer No drug interventions supportive_care Not Available terminated NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT03911388
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors treatment 1 active_not_recruiting NCT02871856
International Lung Screen Trial (ILST) No drug interventions screening Not Available active_not_recruiting NCT02254915
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I No drug interventions treatment 3 withdrawn NCT04493632
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. No drug interventions Not Available Not Available recruiting NCT01995942
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial No drug interventions Not Available Not Available unknown_status NCT01043913
Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue No drug interventions treatment 2 completed NCT05113134
Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Specimen No drug interventions treatment Not Available completed NCT02960724
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer No drug interventions diagnostic 2 unknown_status NCT01629758
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors treatment 1 completed NCT05602935
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study treatment 2 active_not_recruiting NCT06177925
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC treatment 2 recruiting NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06365866
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. No drug interventions treatment Not Available recruiting NCT06237920
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab treatment 2 recruiting NCT00377520
A Trial for Patients With Advanced/Recurrent Endometrial Cancer treatment 2 completed NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT00050427
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer treatment 2 completed NCT00384891
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer No drug interventions treatment 3 terminated NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT03091192
Savolitinib vs. Sunitinib in MET-driven PRCC. treatment 3 active_not_recruiting NCT00341692
Studying Normal Breast Tissue and Cancer Risk No drug interventions Not Available Not Available completed NCT04061967
SMS-based Summons in Cervical Screening No drug interventions prevention Not Available recruiting NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT03134872
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC treatment 3 completed NCT04697446
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC No drug interventions Not Available Not Available unknown_status NCT03003195
The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients No drug interventions treatment 2 withdrawn NCT00050414
A Study of Trabectedin in Patients With Advanced Ovarian Cancer treatment 2 completed NCT04080843
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients treatment 2 completed NCT01917279
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC treatment 3 unknown_status NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) treatment 1 active_not_recruiting NCT04124198
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma treatment Not Available recruiting NCT03569605
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies No drug interventions supportive_care Not Available completed NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT05252078
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients treatment 2 recruiting NCT01968109
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors treatment 1 / 2 active_not_recruiting NCT04461509
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy other 2 active_not_recruiting NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT01556815
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors treatment 2 terminated NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers treatment 2 / 3 recruiting NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer treatment 2 unknown_status NCT01427400
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction treatment 4 unknown_status NCT04679675
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial No drug interventions health_services_research Not Available completed NCT01037049
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks No drug interventions other 2 unknown_status NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC treatment 2 active_not_recruiting NCT05716113
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL No drug interventions treatment 0 recruiting NCT03656718
A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) treatment 1 / 2 active_not_recruiting NCT06494241
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study No drug interventions Not Available Not Available not_yet_recruiting NCT00562224
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients treatment 1 completed NCT02111824
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy diagnostic 1 terminated NCT05980416
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 treatment 1 recruiting NCT05322486
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases No drug interventions Not Available Not Available unknown_status NCT01964430
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) treatment 3 completed NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT04807166
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer treatment 2 active_not_recruiting NCT02005965
Low Rectal Cancer Study (MERCURY II) No drug interventions Not Available Not Available unknown_status NCT04949282
Spanish Series of Patients Treated With the Radionuclide Lutetium177 Not Available Not Available recruiting NCT05895994
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies No drug interventions treatment 0 recruiting NCT01576380
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients treatment 2 completed NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. treatment 2 / 3 recruiting NCT06004440
Real World Registry for Use of the Ion Endoluminal System No drug interventions Not Available Not Available recruiting NCT05022667
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy No drug interventions prevention Not Available recruiting NCT01472146
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer treatment 2 completed NCT05386108
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast Cancer treatment 1 / 2 recruiting NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT05770102
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition treatment 2 / 3 recruiting NCT06376084
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC No drug interventions Not Available Not Available recruiting